Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy

Journal of General Internal Medicine

Volumn 27, Issue 6, 2012, Pages 653-660

  So, Cynthia ^a   Kirby, Katharine A ^b   Mehta, Kala ^b   Hoffman, Richard M ^c   Powell, Adam A ^d   Freedland, Stephen J ^e   Sirovich, Brenda ^f   Yano, Elizabeth M ^g   Walter, Louise C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e DUKE UNIVERSITY   (United States)

^f UCLA School of Public Health ^*  (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

elderly; life expectancy; PSA screening; regional variation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACADEMIC ACHIEVEMENT; AGED; ANTIGEN DETECTION; ARTICLE; ELDERLY CARE; HOSPITAL; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; SCORING SYSTEM; SCREENING TEST;

AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; GUIDELINE ADHERENCE; HUMANS; LIFE EXPECTANCY; MALE; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PROFESSIONAL PRACTICE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SOCIOECONOMIC FACTORS; UNITED STATES; VETERANS HEALTH;

EID: 84862705568     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-011-1945-9     Document Type: Article

References (45)

1. RA Smith V Cokkinides HJ Eyre 2003 American Cancer Society Guidelines for the early detection of cancer, 2003 CA Cancer J Clin 53 27 43 12568442 10.3322/canjclin.53.1.27
2. KL Greene PC Albertsen RJ Babaian, et al. 2009 Prostate specific antigen best practice statement: 2009 update J Urol 182 5 2232 2241 19781717 10.1016/j.juro.2009.07.093 1:CAS:528:DC%2BD1MXhtlyqu7bF
3. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2002;137:915-6.
4. ED Crawford R Grubb 3rd A Black, et al. 2011 Comorbidity and mortality results from a randomized prostate cancer screening trial J Clin Oncol 29 4 355 361 21041707 10.1200/JCO.2010.30.5979
5. K Stamatiou A Alevizos A Mariolis, et al. 2008 Do clinically insignificant tumors of the prostate exist? Urol Int 81 4 379 382 19077395 10.1159/000167832 1:STN:280:DC%2BD1M%2FivFamug%3D%3D
6. LE Ross RJ Coates N Breen RJ Uhler AL Potosky D Blackman 2004 Prostate-specific antigen test use reported in the 2000 National Health Interview Survey Prev Med 38 6 732 744 15193893 10.1016/j.ypmed.2004.01.005
7. LC Walter D Bertenthal K Lindquist BR Konety 2006 PSA screening among elderly men with limited life expectancies JAMA 296 19 2336 2342 17105796 10.1001/jama.296.19.2336 1:CAS:528:DC%2BD28Xht1ansLjK
8. BE Sirovich LM Schwartz S Woloshin 2003 Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 289 11 1414 1420 12636464 10.1001/jama.289.11.1414
9. J Bynum Y Song E Fisher 2010 Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare J Am Geriatr Soc 58 4 674 680 20345867 10.1111/j.1532-5415.2010.02761.x
10. G Lu-Yao TA Stukel SL Yao 2003 Prostate-specific antigen screening in elderly men J Natl Cancer Inst 95 23 1792 1797 14652241 10.1093/jnci/djg104
11. J Li G Zhao LA Pollack JL Smith DA Joseph 2010 Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System Prev Chronic Dis 7 4 A84 20550842
12. JL Freeman CN Klabunde N Schussler JL Warren BA Virnig GS Cooper 2002 Measuring breast, colorectal, and prostate cancer screening with Medicare claims data Med Care 40 suppl IV 36 42
13. Yano EM, Simon B, Canelo I, Mittman B, Rubenstein LV. 1999 VHA Survey of Primary Care Practices, Technical Monograph #00-MC12. Sepulveda, CA: VA HSR&D Center of Excellence for the Study of Healthcare Provider Behavior; 2000.
14. EM Yano LM Soban PH Parkerton DA Etzioni 2007 Primary care practice organization influences colorectal cancer screening performance Health Serv Res 42 3, pt 1 1130 1149 17489907 10.1111/j.1475-6773.2006.00643.x
15. Federal Practitioner. 2003 Directory: VA and DoD Health Care Facilities. Chatham, NJ: Quadrant HealthCom Inc; 2003.
16. VA Office of Quality and Performance. FY 2003. VHA performance measurement system technical manual 2003. Available at: http://vaww.archive.oqp. med.va.gov/oqp-services/performance-measurement/tech-man.asp. Accessed February 28, 2011.
17. RA Deyo DC Cherkin MA Ciol 1992 Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 6 613 619 1607900 10.1016/0895-4356(92)90133-8 1:STN:280:DyaK38zgtVeqsA%3D%3D
18. LC Walter KE Covinsky 2001 Cancer screening in elderly Patients: a framework for individualized decision making JAMA 285 21 2750 2756 11386931 10.1001/jama.285.21.2750 1:STN:280:DC%2BD3MzltVCgsw%3D%3D
19. CE Kistler KA Kirby D Lee MA Casadei LC Walter 2011 Long-term outcomes following positive fecal occult blood test results in older adults: benefits and burdens Arch Intern Med 171 15 1344 1351 21555655 10.1001/archinternmed.2011. 206 Epub 2011 May 9
20. LA McNutt C Wu X Xue JP Hafner 2003 Estimating the relative risk in cohort studies and clinical trials of common outcomes Am J Epidemiol 157 10 940 943 12746247 10.1093/aje/kwg074
21. Little RJA, Rubin DB. Statistical Analysis with Missing Data. 2nd ed. New York: John Wiley & Sons; 2002.
22. PA Shaw R Etzioni SB Zeliadt, et al. 2004 An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States Am J Epidemiol 160 11 1059 1069 15561985 10.1093/aje/kwh336
23. JA Henderson DK Espey MA Jim RR German KM Shaw RM Hoffman 2008 Prostate cancer incidence among American Indian and Alaska Native men, US, 1999-2004 Cancer 113 (5)(suppl) 1203 1212 18720376 10.1002/cncr.23739
24. B Sirovich PM Gallagher DE Wennberg ES Fisher 2008 Discretionary decision making by primary care physicians and the cost of U.S. Health care Health Aff (Millwood) 27 3 813 823 10.1377/hlthaff.27.3.813
25. MM Cooper 1996 The Dartmouth Atlas of Health Care: what is it telling us? Health Syst Rev 29 3 44 45 10158559 1:STN:280:DyaK283psFygsw%3D%3D 47
26. MM Collins MJ Barry 1996 Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate JAMA 276 24 1976 1979 8971068 10.1001/jama.1996.03540240054031 1:STN:280:DyaK2s7is1Wntg%3D%3D
27. C Purvis Cooper TL Merritt LE Ross LV John CM Jorgensen 2004 To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test Prev Med 38 181 191 10.1016/j.ypmed.2003.09.035
28. DL Anthony MB Herndon PM Gallagher, et al. 2009 How much do patients' preferences contribute to resource use? Health Aff (Millwood) 28 3 864 873 10.1377/hlthaff.28.3.864
29. JD Voss JM Schectman 2001 Prostate cancer screening practices and beliefs J Gen Intern Med 16 12 831 837 11903762 10.1046/j.1525-1497.2001.10133.x 1:STN:280:DC%2BD387mvF2htw%3D%3D
30. OJ Austin S Valente LA Hasse JR Kues 1997 Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians Arch Fam Med 6 5 453 458 9305688 10.1001/archfami.6.5.453 1:STN:280:DyaK2svkvFaiuw%3D%3D
31. RJ Hicks RM Hamm DA Bemben 1995 Prostate cancer screening. What family physicians believe is best Arch Fam Med 4 4 317 322 7711917 10.1001/archfami.4. 4.317 1:STN:280:DyaK2M3islektQ%3D%3D
32. Tasian GE, Cooperberg MR, Cowan JE, et al. Prostate specific antigen screening for prostate cancer: Knowledge of, attitudes towards, and utilization among primary care physicians. Urol Oncol. Epub 2010
33. A Hartz J Lucas T Cramm, et al. 2002 Physician surveys to assess customary care in medical malpractice cases J Gen Intern Med 17 7 546 555 12133145 10.1046/j.1525-1497.2002.10740.x
34. SB Menees DA Patel V Dalton 2009 Colorectal cancer screening practices among obstetrician/gynecologists and nurse practitioners J Womens Health (Larchmt) 18 8 1233 1238 10.1089/jwh.2008.1117
35. SV Hudson P Ohman-Strickland R Cunningham JM Ferrante K Hahn BF Crabtree 2007 The effects of teamwork and system support on colorectal cancer screening in primary care practices Cancer Detect Prev 31 5 417 423 18031947 10.1016/j.cdp.2007.08.004
36. BP Kerfoot EF Holmberg EV Lawler E Krupat PR Conlin 2007 Practitioner-level determinants of inappropriate prostate-specific antigen screening Arch Intern Med 167 13 1367 1372 17620529 10.1001/archinte.167.13.1367
37. LC Walter NP Davidowitz PA Heineken KE Covinsky 2004 Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure JAMA 291 20 2466 2470 15161897 10.1001/jama.291.20.2466 1:CAS:528:DC%2BD2cXksVegsL0%3D
38. LP Casalino 1999 The unintended consequences of measuring quality on the quality of medical care N Engl J Med 341 15 1147 1150 10511617 10.1056/NEJM199910073411511 1:STN:280:DyaK1Mvis1GqsQ%3D%3D
39. M Fisher 2002 Is prostate-specific antigen (PSA) screening indicated for any subgroup of men? J Fam Pract 51 2 113 11978206
40. U.S. Preventive Services Task Force. Screening for Prostate Cancer: Draft Recommendation Statement. Available at: www.uspreventiveservicestaskforce.org/ draftrec3.htm. Accessed October 16, 2011.
41. SV Hudson P Ohman-Strickland JM Ferrante G Lu-Yao AJ Orzano BF Crabtree 2009 Prostate-specific antigen testing among the elderly in community-based family medicine practices J Am Board Fam Med 22 3 257 265 19429731 10.3122/jabfm.2009.03.080136
42. HG Welch PC Albertsen RF Nease TA Bubolz JH Wasson 1996 Estimating treatment benefits for the elderly: the effect of competing risks Ann Intern Med 124 6 577 584 8597322 1:STN:280:DyaK287nsFKmtQ%3D%3D
43. RJ Volk ST Hawley S Kneuper, et al. 2007 Trials of decision aids for prostate cancer screening: a systematic review Am J Prev Med 33 5 428 434 17950409 10.1016/j.amepre.2007.07.030
44. DL Frosch RM Kaplan VJ Felitti 2003 A randomized controlled trial comparing internet and video to facilitate patient education for men considering the prostate specific antigen test J Gen Intern Med 18 10 781 787 14521639 10.1046/j.1525-1497.2003.20911.x
45. Bellizzi KM, Breslau ES, Burness A, Waldron W. Still screening after all these years. Prevalence and correlates of cancer screening in older racially diverse adults. Arch Intern Med. Forthcoming 2011.